Zinc Acetate Lozenges May Improve the Recovery Rate of Common Cold Patients : An Individual Patient Data Meta-Analysis

Show full item record



Permalink

http://hdl.handle.net/10138/231462

Citation

Hemilä , H , Fitzgerald , J T , Petrus , E J & Prasad , A 2017 , ' Zinc Acetate Lozenges May Improve the Recovery Rate of Common Cold Patients : An Individual Patient Data Meta-Analysis ' , Open Forum Infectious Diseases , vol. 4 , no. 2 , ofx059 . https://doi.org/10.1093/ofid/ofx059

Title: Zinc Acetate Lozenges May Improve the Recovery Rate of Common Cold Patients : An Individual Patient Data Meta-Analysis
Author: Hemilä, Harri; Fitzgerald, James T.; Petrus, Edward J.; Prasad, Ananda
Contributor: University of Helsinki, Harri Hemilä / Principal Investigator
Date: 2017-04-03
Language: eng
Number of pages: 6
Belongs to series: Open Forum Infectious Diseases
ISSN: 2328-8957
URI: http://hdl.handle.net/10138/231462
Abstract: BACKGROUND: A previous meta-analysis of 3 zinc acetate lozenge trials estimated that colds were on average 40% shorter for the zinc groups. However, the duration of colds is a time outcome, and survival analysis may be a more informative approach. The objective of this individual patient data (IPD) meta-analysis was to estimate the effect of zinc acetate lozenges on the rate of recovery from colds. METHODS: We analyzed IPD for 3 randomized placebo-controlled trials in which 80-92 mg/day of elemental zinc were administered as zinc acetate lozenges to 199 common cold patients. We used mixed-effects Cox regression to estimate the effect of zinc. RESULTS: Patients administered zinc lozenges recovered faster by rate ratio 3.1 (95% confidence interval, 2.1-4.7). The effect was not modified by age, sex, race, allergy, smoking, or baseline common cold severity. On the 5th day, 70% of the zinc patients had recovered compared with 27% of the placebo patients. Accordingly, 2.6 times more patients were cured in the zinc group. The difference also corresponds to the number needed to treat of 2.3 on the 5th day. None of the studies observed serious adverse effects of zinc. CONCLUSIONS: The 3-fold increase in the rate of recovery from the common cold is a clinically important effect. The optimal formulation of zinc lozenges and an ideal frequency of their administration should be examined. Given the evidence of efficacy, common cold patients may be instructed to try zinc acetate lozenges within 24 hours of onset of symptoms.
Subject: 3142 Public health care science, environmental and occupational health
317 Pharmacy
3125 Otorhinolaryngology, ophthalmology
common cold
meta-analysis
randomized controlled trials
respiratory tract infections
zinc acetate
Rights:


Files in this item

Total number of downloads: Loading...

Files Size Format View
2017_OFID.pdf 161.2Kb PDF View/Open

This item appears in the following Collection(s)

Show full item record